Boston Partners’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Boston Partners’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,878,696	Closed	-$397M	–	775
2014 Q4	$397M	Sell	3,878,696 -52,295	-1%	-$5.02M	0.6%	46
2014 Q3	$340M	Sell	3,930,991 -1,219,914	-24%	-$108M	0.55%	56
2014 Q2	$465M	Buy	5,150,905 +181,338	+4%	+$13.6M	0.78%	35
2014 Q1	$366M	Buy	4,969,567 +295,213	+6%	+$20.6M	0.67%	39
2013 Q4	$318M	Buy	4,674,354 +201,156	+4%	+$13.1M	0.65%	42
2013 Q3	$273M	Sell	4,473,198 -942,533	-17%	-$57.5M	0.66%	37
2013 Q2	$302M	Buy	+5,415,731	New	+$313M	0.83%	31

Boston Partners's COV Position: Q1 2015 in Review

Boston Partners sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 3,878,696 shares — an estimated $397M sold.

Boston Partners first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $465M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Boston Partners reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Boston Partners sold 3,878,696 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $397M.
Boston Partners first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
Boston Partners's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $465M in Q2 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.